These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24837308)

  • 1. [Computer modeling of blood brain barrier permeability of physiologically active compounds].
    Raevskiĭ OA; Solodova SL; Lagunin AA; Poroĭkov VV
    Biomed Khim; 2014; 60(2):161-81. PubMed ID: 24837308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing Enhanced Blood-Brain Barrier Permeability Models: Integrating External Bio-Assay Data in QSAR Modeling.
    Wang W; Kim MT; Sedykh A; Zhu H
    Pharm Res; 2015 Sep; 32(9):3055-65. PubMed ID: 25862462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR modeling of the blood-brain barrier permeability for diverse organic compounds.
    Zhang L; Zhu H; Oprea TI; Golbraikh A; Tropsha A
    Pharm Res; 2008 Aug; 25(8):1902-14. PubMed ID: 18553217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
    Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
    Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood Brain Barrier Permeability Prediction Using Machine Learning Techniques: An Update.
    Saxena D; Sharma A; Siddiqui MH; Kumar R
    Curr Pharm Biotechnol; 2019; 20(14):1163-1171. PubMed ID: 31433750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.
    Vucicevic J; Nikolic K; Dobričić V; Agbaba D
    Eur J Pharm Sci; 2015 Feb; 68():94-105. PubMed ID: 25542610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ionization-specific QSAR models of blood-brain penetration of drugs.
    Lanevskij K; Japertas P; Didziapetris R; Petrauskas A
    Chem Biodivers; 2009 Nov; 6(11):2050-4. PubMed ID: 19937840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive model of blood-brain barrier penetration of organic compounds.
    Ma XL; Chen C; Yang J
    Acta Pharmacol Sin; 2005 Apr; 26(4):500-12. PubMed ID: 15780201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting blood-brain barrier partitioning of organic molecules using membrane-interaction QSAR analysis.
    Iyer M; Mishra R; Han Y; Hopfinger AJ
    Pharm Res; 2002 Nov; 19(11):1611-21. PubMed ID: 12458666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling blood-brain barrier partitioning using Bayesian neural nets.
    Winkler DA; Burden FR
    J Mol Graph Model; 2004 Jul; 22(6):499-505. PubMed ID: 15182809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational prediction of blood-brain barrier permeability using decision tree induction.
    Suenderhauf C; Hammann F; Huwyler J
    Molecules; 2012 Aug; 17(9):10429-45. PubMed ID: 22941223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Simple Method to Predict Blood-Brain Barrier Permeability of Drug- Like Compounds Using Classification Trees.
    Castillo-Garit JA; Casanola-Martin GM; Le-Thi-Thu H; Pham-The H; Barigye SJ
    Med Chem; 2017; 13(7):664-669. PubMed ID: 28185535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-silico prediction of blood-brain barrier permeability.
    Yan A; Liang H; Chong Y; Nie X; Yu C
    SAR QSAR Environ Res; 2013 Jan; 24(1):61-74. PubMed ID: 23092117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of blood-brain barrier penetration: in silico, in vitro and in vivo.
    Feng MR
    Curr Drug Metab; 2002 Dec; 3(6):647-57. PubMed ID: 12369891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.
    Allen DD; Geldenhuys WJ
    Life Sci; 2006 Feb; 78(10):1029-33. PubMed ID: 16126231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand and Structure-based Modeling of Passive Diffusion through the Blood-Brain Barrier.
    Vilar S; Sobarzo-Sanchez E; Santana L; Uriarte E
    Curr Med Chem; 2018; 25(9):1073-1089. PubMed ID: 29110594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ionization-specific prediction of blood-brain permeability.
    Lanevskij K; Japertas P; Didziapetris R; Petrauskas A
    J Pharm Sci; 2009 Jan; 98(1):122-34. PubMed ID: 18481317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico modeling on ADME properties of natural products: Classification models for blood-brain barrier permeability, its application to traditional Chinese medicine and in vitro experimental validation.
    Zhang X; Liu T; Fan X; Ai N
    J Mol Graph Model; 2017 Aug; 75():347-354. PubMed ID: 28628860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of topochemical models for the prediction of permeability through the blood-brain barrier.
    Dureja H; Madan AK
    Acta Pharm; 2007 Dec; 57(4):451-67. PubMed ID: 18165189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.